AnaptysBio, Inc. ($ANAB)
Filing Information
| Accession Number | 0001673528-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 8, 2026 |
| Document Date | Jan 6, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
276,902
Total Value
$415,102.22
P&L
+inf% (+$14,468,680.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 6, 2026 | Exercise/Conversion | 17,850 | โ | โ | 475,989 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 7, 2026 | Sale | 9,202 | $45.11 | $415,102.22 | 466,787 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | Jan 6, 2026 | Exercise/Conversion | 17,850 | $0.00 | $0.00 | 17,850 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | Jan 6, 2026 | Grant/Award | 98,600 | $0.00 | $0.00 | 98,600 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jan 6, 2026 | Grant/Award | 133,400 | $0.00 | $0.00 | 133,400 | Direct | โ | View Details |